News

A Food and Drug Administration (FDA) expert panel has reignited a debate over whether hormone therapy should be used to treat ...
Dr. Marty Makary, the agency’s commissioner, said too many women avoid hormone therapy because the risks have been overstated ...
A panel selected by FDA Commissioner Marty Makary, MD, MPH, unanimously urged the agency to remove the boxed warning on ...
On Thursday in Washington, D.C., the U.S. Food and Drug Administration (FDA) convened a panel of top experts to reassess the ...
“The role of testosterone is just a lesson in gender bias,” says Kelly Casperson, MD, a urologist. “Because 100 percent of ...
Her doctor prescribed an antidepressant, even though the then 36-year-old insisted she wasn’t depressed. She even went to ...
The FDA is reconsidering the black box warning on estrogen. Experts say it’s time for a change—find out what this means for ...
The Food and Drug Administration is reassessing some warnings given about hormone therapy treatments for menopause that have ...
Experts worry the warning on vaginal estrogen menopause treatments is doing more harm than good and is not supported by science.
The panelists said that vaginal creams and other localized therapies for menopause are safe and vastly underused by women who could benefit.
Hone Health reports that the controversial 2002 WHI study misled menopause care, linking HRT to breast cancer and causing ...
As a Menopause Society Certified Practitioner, Flanagan educates women about the most up-to-date evidence-based medicine and ...